LUTHERVILLE, Md., April 10, 2012 /PRNewswire/ -- The National Association of Drug Diversion Investigators (NADDI) – a nonprofit organization that facilitates cooperation between law enforcement, healthcare professionals, state regulatory agencies and pharmaceutical manufacturers in the prevention and investigation of drug diversion – today lauded the latest quarterly results achieved by the real-time, stop-sale system in Alabama. The National Precursor Log Exchange (NPLEx) released quarterly data for 2012 which shows electronic technology in Alabama blocked the sale of more than 19,500 boxes of medicines containing pseudoephedrine (PSE) preventing more than 48,000 grams from potentially being diverted by meth criminals. NPLEx was fully implemented in Alabama in January 2011.
"Alabama's real-time, stop-sale technology continues to produce serious results," said Charles F. Cichon, executive director of the National Association of Drug Diversion Investigators (NADDI). "NPLEx is working to prevent would-be meth criminals from obtaining effective and basic medicines containing pseudoephedrine, while providing police officers with an invaluable tool to track criminal activity. Just as importantly, the technology continues to protect responsible Alabamans' access to popular cold and allergy medicines. "With another busy legislative session under way, Alabama lawmakers should focus on legislation that complements this proven method and sideline any discussion of punishing law-abiding citizens with prescription mandates."
The National Association of Drug Diversion Investigators (NADDI) is a nonprofit 501(c)(3) organization that facilitates cooperation between law enforcement, healthcare professionals, state regulatory agencies, and pharmaceutical manufacturers in the investigation and prevention of prescription drug abuse and diversion. NADDI also sponsors and conducts specialized educational seminars and conferences.
SOURCE National Association of Drug Diversion Investigators